Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Journal of Periodontal Research|June 15, 2007
Lipid A-associated proteins from Porphyromonas gingivalis stimulate release of nitric oxide by inducing expression of inducible nitric oxide synthaseE-Y Choi, Y-M Hwang, J-Y Lee, et al.
Zhonghua Nei Ke Za Zhi|July 5, 2016
[The application of (18)F fluorodeoxyglucose-positron emission tomography/computed tomography in the diagnosis and treatment of dermatomyositis]L Pei, Z W Guan, X J Ji, et al.
CPT: Pharmacometrics & Systems Pharmacology|May 26, 2017
Time-to-Event Analysis of Polatuzumab Vedotin-Induced Peripheral Neuropathy to Assist in the Comparison of Clinical Dosing RegimensD Lu, W R Gillespie, S Girish, et al.
Clinical Pharmacology and Therapeutics|June 29, 2012
Drug absorption interactions between oral targeted anticancer agents and PPIs: is pH-dependent solubility the Achilles heel of targeted therapy?N R Budha, A Frymoyer, G S Smelick, et al.
Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology|August 1, 2023
[Distribution characteristics of tumor infiltrating lymphocytes in EBV-associated lymphoepithelioma-like carcinoma and their clinical significance]J Y Jin, Y Q Lyu, T T Lu, et al.
Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|January 16, 2016
Rumex acetosa L. induces vasorelaxation in rat aorta via activation of PI3-kinase/Akt- AND Ca(2+)-eNOS-NO signaling in endothelial cellsY Y Sun, X H Su, J Y Jin, et al.
Bone Marrow Transplantation|June 1, 1994
Allogeneic bone marrow transplantation in Korea: 1983-92D J Kim, C C Kim, B K Kim, et al.
The Korean Journal of Internal Medicine|January 1, 1995
Immune suppression therapy in aplastic anemia: influencing factors on response and survivalJ Y Jin, D W Kim, J W Lee, et al.
Experimental Hematology|July 2, 1999
Effectiveness of rotor off fraction in allogeneic murine bone marrow transplantation with complete disparity of major histocompatibilityD C Jeong, C W Han, J Y Jin, et al.
Japanese Journal of Clinical Oncology|February 24, 2001
A phase II study of a daily x4 schedule of vinorelbine plus cisplatin for advanced non-small cell lung cancerJ Y Han, K W Kim, J A Kim, et al.
Pageof 6